UNSPSC 51342907: Vidarabine sodium phosphate

This classification denotes an antiviral agent with the molecular structure C10H12N5O7P.2NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, ZEC0WCC7UA chemically known as 9-.beta.-d-arabinofuranosyladenine 5'-(dihydrogen phosphate), disodium salt, but more commonly known as vidarabine sodium phosphate, which bears US NIH Compound Identifier 224. European Medicines Agency schedules Vidarabine sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05095MIG.

UNSPSC 51342907 Vidarabine sodium phosphate is a Commodity code that in recent state and local procurement activity captures a much broader range of pharmaceutical and medical supply purchasing than the code name alone suggests. State and local governments are using this code to solicit naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription fulfillment capabilities. The issuing bodies span county health departments, state health and human services agencies, city fire departments, and cooperative purchasing alliances serving multiple state and local jurisdictions. Procurement vehicles include competitive sealed bids (IFB), requests for proposal (RFP), and requests for information (RFI) used to gather preliminary market intelligence before formal solicitations.

Recent activity clusters in Florida, Texas, Minnesota, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities, with awarded vendors required to work through authorized wholesalers and submit detailed product information including NDC codes and manufacturing locations. Seminole County, Florida posted IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on March 27, 2026, closing April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs for self-insured employee group health plans and state agencies. The City of Tampa released IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a small local business enterprise set-aside designation providing a 5 percent bid discount capped at $10,000.